NCT03748563

Brief Summary

This is a diagnostic accuracy study. Eligible individuals will be enrolled and asked to undergo ds-MCE and EGD examinations. EGD is the reference standard against which ds-MCE is compared, and it will be performed within 48 hours after ds-MCE examination. The primary outcome is the sensitivity and specificity of ds-MCE in identifying the presence of esophagogastric (EGV) in patients with cirrhosis, using detection by EGD as the reference. The diagnostic accuracy of ds-MCE in detection of high-risk EV, high-risk EGV, EV, large EV, red signs of EV, GV, cardiofundal GV and PHG compared with the EGD will also be assessed. The incidence of PHE in small bowel under ds-MCE, the examination time of ds-MCE and EGD procedures, patient satisfaction assessment and safety evaluation will also be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
607

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 12, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 21, 2018

Completed
2.1 years until next milestone

Study Start

First participant enrolled

January 7, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2023

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

2 years

First QC Date

November 12, 2018

Last Update Submit

July 28, 2023

Conditions

Keywords

Capsule EndoscopyLiver CirrhosisEsophageal VaricesGastric VaricesPortal hypertensive gastropathyPortal hypertensive enteropathy

Outcome Measures

Primary Outcomes (1)

  • the diagnostic accuracy of the ds-MCE in identifying the presence of esophagogastric varices (EGV)

    the sensitivity and specificity of ds-MCE in identifying EGV in patients with cirrhosis, using the detection by EGD as the reference.

    2 weeks

Secondary Outcomes (13)

  • the diagnostic accuracy of the ds-MCE in identifying the presence of esophageal varices (EV)

    2 weeks

  • the diagnostic accuracy of the ds-MCE in identifying the red sign of EV

    2 weeks

  • the diagnostic accuracy of the ds-MCE in differentiating large esophageal varices

    2 weeks

  • the optimal esophageal luminal circumference percentage threshold under ds-MCE for distinguishing large EV

    2 weeks

  • the diagnostic accuracy of the ds-MCE in differentiating high-risk esophageal varices

    2 weeks

  • +8 more secondary outcomes

Study Arms (1)

ds-MCE and EGD

EXPERIMENTAL

All the enrolled participants will undergo the examination of detachable string magnetically maneuvered capsule endoscopy (ds-MCE) first, followed by EGD within 48 hours.

Diagnostic Test: ds-MCE and EGD

Interventions

ds-MCE and EGDDIAGNOSTIC_TEST

Procedure of ds-MCE: The ds-MCE system mainly consists of two parts: the NaviCam magnetically maneuvered capsule endoscopy system and the detachable string part. The capsule, which is partially enclosed within the sleeve, can be actively moved in the esophagus through the control of string. Investigator can examine the entire esophagus several times under real time views. After completing the esophageal examination, the capsule could be detached from the string through injecting air into the hollow string with the syringe. Then, the examination of stomach under magnetic control and small bowel under the natural action of gastrointestinal peristalsis follows. Procedure of EGD: The esophagogastroduodenoscopy (EGD) will be performed using conventional upper gastrointestinal video endoscopy, according to the standard procedure at individual centers. EGD will be performed within 48 hours after ds-MCE procedure and usually during the same endoscopic session.

ds-MCE and EGD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gender is not limited.
  • Patients aged 18 years or older.
  • Both inpatients and outpatients.
  • Clinically evident or biopsy-proven liver cirrhosis.
  • Able to provide informed consent.

You may not qualify if:

  • Patients aged less than 18 years.
  • Patients with Zenker's diverticulum.
  • Patients with active gastrointestinal bleeding.
  • Patients who have participated in or are participating in other clinical trials.
  • Pregnancy or suspected pregnancy.
  • Suspected or known intestinal stenosis or other known risk factors for capsule retention.
  • Pacemaker or other implanted electromedical devices which could interfere with magnetic resonance.
  • Patients with dysphagia.
  • Life-threatening conditions.
  • Patients plan to undergo magnetic resonance imaging examination before excretion of the MCE.
  • Patients who refuse to give informed consent.
  • Patients with any condition that precludes compliance with the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Zhujiang Hospital,Southern Medical University

Guangzhou, Guangdong, 510000, China

Location

the Fifth Affiliated Hospital of Zunyi Medical University

Zhuhai, Guangdong, 519000, China

Location

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430000, China

Location

The Third Xiangya Hospital of Central South University

Changsha, Hunan, 410000, China

Location

Qilu Hospital of Shandong University

Jinan, Shandong, 250000, China

Location

Ruijin Hospital

Shanghai, Shanghai Municipality, 200000, China

Location

Shanghai East Hospital, Tongji University School of Medicine

Shanghai, Shanghai Municipality, 200000, China

Location

Shanghai Jiao Tong University affiliated Sixth people's Hospital

Shanghai, Shanghai Municipality, 200000, China

Location

Shanghai Tongji Hospital, Tongji University School of Medicine

Shanghai, Shanghai Municipality, 200000, China

Location

Shanghai Pudong New Area Gongli Hospital

Shanghai, Shanghai Municipality, 200135, China

Location

Yangpu District Central Hospital Affiliated to Tongji University

Shanghai, Shanghai Municipality, 200433, China

Location

First Affiliated Hospital Xi'an Jiaotong University

Xi’an, Shanxi, 710000, China

Location

The First Affiliated Hospital of Zhejiang Chinese Medical University

Hanzhou, Zhejiang, 310000, China

Location

Changhai Hospital

Shanghai, 200433, China

Location

Related Publications (11)

  • de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3. No abstract available.

    PMID: 26047908BACKGROUND
  • North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988 Oct 13;319(15):983-9. doi: 10.1056/NEJM198810133191505.

    PMID: 3262200BACKGROUND
  • Spina GP, Arcidiacono R, Bosch J, Pagliaro L, Burroughs AK, Santambrogio R, Rossi A. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol. 1994 Sep;21(3):461-7. doi: 10.1016/s0168-8278(05)80329-0. No abstract available.

    PMID: 7836719BACKGROUND
  • Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992 Dec;16(6):1343-9. doi: 10.1002/hep.1840160607.

    PMID: 1446890BACKGROUND
  • Kodama M, Uto H, Numata M, Hori T, Murayama T, Sasaki F, Tsubouchi N, Ido A, Shimoda K, Tsubouchi H. Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy. J Gastroenterol. 2008;43(8):589-96. doi: 10.1007/s00535-008-2198-1. Epub 2008 Aug 17.

    PMID: 18709480BACKGROUND
  • D'Amico G, De Franchis R; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003 Sep;38(3):599-612. doi: 10.1053/jhep.2003.50385.

    PMID: 12939586BACKGROUND
  • Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007 Sep;46(3):922-38. doi: 10.1002/hep.21907. No abstract available.

    PMID: 17879356BACKGROUND
  • Lapalus MG, Dumortier J, Fumex F, Roman S, Lot M, Prost B, Mion F, Ponchon T. Esophageal capsule endoscopy versus esophagogastroduodenoscopy for evaluating portal hypertension: a prospective comparative study of performance and tolerance. Endoscopy. 2006 Jan;38(1):36-41. doi: 10.1055/s-2006-924975.

    PMID: 16429353BACKGROUND
  • Gralnek IM, Adler SN, Yassin K, Koslowsky B, Metzger Y, Eliakim R. Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2. Endoscopy. 2008 Apr;40(4):275-9. doi: 10.1055/s-2007-995645.

    PMID: 18389444BACKGROUND
  • de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, Fisher L, Vargas HE, Vargo J, Thompson J, Eliakim R. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008 May;47(5):1595-603. doi: 10.1002/hep.22227.

    PMID: 18435461BACKGROUND
  • Jiang X, Pan J, Xu Q, Song YH, Sun HH, Peng C, Qi XL, Qian YY, Zou WB, Yang Y, Jin SQ, Duan BS, Wu S, Chu Y, Xiao DH, Hu LJ, Cao JZ, Dai JF, Liu X, Xia T, Zhou W, Chen T, Zhou CH, Wu W, Liu SJ, Yang ZY, Wang F, Zhang L, Li CZ, Xu H, Wang JX, Wei B, Lin Y, Deng X, Qu LH, Shen YQ, Wang H, Huang YF, Bao HB, Zhang S, Li L, Shi YH, Wang XY, Zou DW, Wan XJ, Xu MD, Mao H, He CH, Li Z, Zuo XL, He SX, Xie XP, Liu J, Yang CQ, Spada C, Li ZS, Liao Z. Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study. BMJ. 2024 Mar 5;384:e078581. doi: 10.1136/bmj-2023-078581.

MeSH Terms

Conditions

Liver CirrhosisHypertension, PortalEsophageal and Gastric Varices

Interventions

Endoscopy, Digestive System

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsEsophageal DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Zhuan Liao

    Changhai Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Diagnostic accuracy study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 12, 2018

First Posted

November 21, 2018

Study Start

January 7, 2021

Primary Completion

January 10, 2023

Study Completion

March 6, 2023

Last Updated

August 1, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Data can be shared after publication of the main results.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
3 years.
Access Criteria
The website of the journal where the results published, and ClinicalTrials.gov web site.

Locations